Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Tenaya Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-05-22Dec-31-21Dec-05-21Dec-31-20Dec-31-19
Revenues0.094.50.054.40.023.1
            Revenue growth 73.8%  -100.0% 
Cost of goods sold0.0125.60.072.80.027.7
Gross profit0.0-31.10.0-18.40.0-4.6
            Gross margin -32.9% -33.9% -19.7%
Research and development94.5 54.4 31.1 
General and administrative31.131.118.418.47.84.6
EBIT-125.6-125.6-72.8-72.8-38.9-27.7
            EBIT margin -132.9% -133.9% -119.7%
Pre-tax income-123.7-123.7-72.7-72.7-38.4-26.2
Income taxes0.00.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%0.0%
Net income-123.7-123.7-72.7-72.7-38.4-26.2
            Net margin -130.8% -133.7% -113.3%
 
Diluted EPS($2.76)($2.76)($4.10)($4.10)($39.50)($5.78)
Shares outstanding (diluted)44.844.817.717.71.04.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy